1. Sorkin EM, Clissold SP. Nicardipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in the treatment of angina pectoris, hypertension and related cardiovascular disorders. Drugs. 1987; 33:296–345. DOI:
10.2165/00003495-198733040-00002. PMID:
3297616.
2. Nij Bijvank SW, Duvekot JJ. Nicardipine for the treatment of severe hypertension in pregnancy:a review of the literature. Obstet Gynecol Surv. 2010; 65:341–7. DOI:
10.1097/OGX.0b013e3181e2c795. PMID:
20591204.
3. Gáspár R, Hajagos-Tóth J. Calcium channel blockers as tocolytics:principles of their actions, adverse effects and therapeutic combinations. Pharmaceuticals (Basel). 2013; 6:689–99. DOI:
10.3390/ph6060689. PMID:
24276256. PMCID:
PMC3816733.
5. Kilkenny C, Browne W, Cuthill IC, Emerson M, Altman DG. National Centre for the Replacement, Refinement and Reduction of Amimals in Research. Animal research:reporting in vivo experiments--the ARRIVE guidelines. J Cereb Blood Flow Metab. 2011; 31:991–3. DOI:
10.1038/jcbfm.2010.220. PMID:
21206507. PMCID:
PMC3070981.
6. Chung CD, An TH, Jung KT, Lee TH. The effects of etomidate on the contraction of pregnant rat uterine smooth muscle. Korean J Anesthesiol. 2009; 57:84–7. DOI:
10.4097/kjae.2009.57.1.84. PMID:
30625835.
7. Lee SI, Hwang GB, Baik CY. The relationship of the estimates of effective concentration calculated by logit, probit, and sigmoid emax. Korean J Anesthesiol. 2002; 43:345–7. DOI:
10.4097/kjae.2002.43.3.345.
8. Bursztyn L, Eytan O, Jaffa AJ, Elad D. Mathematical model of excitation-contraction in a uterine smooth muscle cell. Am J Physiol Cell Physiol. 2007; 292:1816–29. DOI:
10.1152/ajpcell.00478.2006. PMID:
17267547.
9. Arrowsmith S, Wray S. Oxytocin:its mechanism of action and receptor signalling in the myometrium. J Neuroendocrinol. 2014; 26:356–69. DOI:
10.1111/jne.12154. PMID:
24888645.
10. Carbonne B, Jannet D, Touboul C, Khelifati Y, Milliez J. Nicardipine treatment of hypertension during pregnancy. Obstet Gynecol. 1993; 81:908–14. PMID:
8497354.
11. Bartels PA, Hanff LM, Mathot RA, Steegers EA, Vulto AG, Visser W. Nicardipine in pre-eclamptic patients:placental transfer and disposition in breast milk. BJOG. 2007; 114:230–3. DOI:
10.1111/j.1471-0528.2006.01200.x. PMID:
17166219.
12. Curran MP, Robinson DM, Keating GM. Intravenous nicardipine:its use in the short-term treatment of hypertension and various other indications. Drugs. 2006; 66:1755–82. DOI:
10.2165/00003495-200666130-00010. PMID:
16978041.
13. Ducsay CA, Thompson JS, Wu AT, Novy MJ. Effects of calcium entry blocker (nicardipine) tocolysis in rhesus macaques:fetal plasma concentrations and cardiorespiratory changes. Am J Obstet Gynecol. 1987; 157:1482–6. DOI:
10.1016/S0002-9378(87)80248-X. PMID:
3425651.
14. Doret M, Mellier G, Gaucherand P, Saade GR, Benchaib M, Fru-toso J, et al. The in vitro effect of dual combinations of ritodrine, nicardipine and atosiban on contractility of pregnant rat myometrium. BJOG. 2003; 110:731–4. DOI:
10.1111/j.1471-0528.2003.02443.x. PMID:
12892684.
15. Serena C, Begot E, Cros J, Hodler C, Fedou AL, Nathan-Denizot N, et al. Nicardipine-induced acute pulmonary edema:a rare but severe complication of tocolysis. Case Rep Crit Care 2014. 2014; 242703. DOI:
10.1155/2014/242703. PMID:
25215245. PMCID:
PMC4156995.